Arvinas, Inc (ARVN) Stock Price

12.00 ▼ -0.28 (-2.28%)
Open: 12.53 Vol: 29.19K Day's range: 11.97 - 12.53 Mar 17, 15:59 EDT
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
ARVN Technical Analysis
5 mins 30 mins Hourly Daily Weekly
SELL SELL SELL SELL SELL
  5 mins 30 mins Hourly Daily Weekly
MA5 12.05▼ 12.05▼ 12.10▼ 12.48▼ 12.61▼
MA10 12.05▼ 12.15▼ 12.21▼ 13.07▼ 12.66▼
MA20 12.05▼ 12.24▼ 12.21▼ 12.92▼ 12.23▼
MA50 12.15▼ 12.29▼ 12.86▼ 12.75▼ 9.60▲
MA100 12.23▼ 12.89▼ 13.12▼ 12.05▼ 16.53▼
MA200 12.24▼ 13.11▼ 12.83▼ 9.95▲ 25.70▼
  5 mins 30 mins Hourly Daily Weekly
MACD 0.003▲ -0.022▼ 0.009▲ -0.165▼ -0.063▼
RSI 38.944▼ 32.431▼ 31.259▼ 39.866▼ 51.831▲
STOCH 43.981     15.556▼ 26.662     24.400     44.866    
WILL %R -80.645▼ -94.643▼ -94.643▼ -96.911▼ -71.510    
CCI -148.755▼ -130.879▼ -165.068▼ -146.451▼ -40.615    
Latest Filters Detected On ARVN
▼ MACD $ARVN MACD(12,26,9) Crossed Below Zero Set Alert
▲ GAP $ARVN Open Gap Up %2 Set Alert
CDL $ARVN Marubozu Candlestick Pattern Detected Set Alert
Arvinas, Inc News
Arvinas to Present Phase 1 Data for ARV-102, a PROTAC LRRK2 Degrader, in Oral Session at the 2026 International Conference on Alzheimer’s and Parkinson’s Diseases and ...
Wednesday, March 11, 2026 04:34 AM
Company to highlight new safety, pharmacokinetic, and pharmacodynamic data from Phase 1 clinical trial of ARV-102 in participants with ...
Arvinas Highlights Phase 1 Shift, 2026 Data Catalysts, and Vepdegestrant NDA at Barclays Conference
Wednesday, March 11, 2026 03:21 AM
Arvinas (NASDAQ:ARVN) executives outlined a portfolio shift toward early-stage development and previewed multiple clinical catalysts in a discussion hosted by Barclays biotech analyst Esra Darroudi. C ...
Arvinas Teases Near-Term Phase 1 Data, Eyes New Vepdegestrant Partner at Leerink Conference
Tuesday, March 10, 2026 05:21 AM
Executives from Arvinas (NASDAQ:ARVN) outlined the company’s clinical pipeline and near-term milestones during a presentation at Leerink Partners’ Global Healthcare Conference, emphasizing multiple ...
ARVN historical stock data
date open high low close volume
17/03/26 12.53 12.53 11.965 12.00 744,489
16/03/26 12.37 12.495 12.25 12.28 593,619
13/03/26 12.38 12.70 11.92 12.18 689,352
12/03/26 13.23 13.31 12.27 12.48 729,323
11/03/26 13.74 13.8638 13.22 13.48 525,810
10/03/26 14.32 14.51 13.745 13.83 741,503
09/03/26 13.21 13.79 13.07 13.37 591,047
06/03/26 13.37 13.66 12.85 13.60 814,356
05/03/26 13.72 13.98 13.1763 13.72 1,051,882
04/03/26 13.50 13.93 13.295 13.76 761,455
Quote Details
52wk Low:5.90
52wk High:14.51
Vol:29.19K
Avg Vol(3m):13.2M
1Y Chng:+67.13%
1M Chng:-12.09%
Add to Watch List
More Information
Index US Composite
Market Cap. 782.25M